Bruton's tyrosine kinase inhibition: a novel treatment option for Sjögren's syndrome?

Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?

Presented By

Prof. Thomas Dörner, Charité University Hospital, Germany

Trial

Phase 2, LOUiSSE

Conference

ACR 2022

1 December, 2022 13:19

Presented By

Prof. Marcus Maurer, Charité University Hospital, Germany

Trial

Phase 2

Conference

EADV 2021

18 November, 2021 13:33